Relief Therapeutics Holding SA (ETR:RLF) | WebDisclosure

Basculer en Français

10793	Companies
233130	Keywords
161733	Articles
124357	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

PRESS RELEASE

published on 10/29/2024 at 07:00, 1 year 9 months ago

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE
Relief Therapeutics announced the publication of a Plain Language Summary on PKU GOLIKE for phenylketonuria management, highlighting findings on prolonged-release protein substitute with similarities to natural proteins

Medical Research Relief Therapeutics PKU GOLIKE Phenylketonuria Plain Language Summary
BRIEF

published on 10/25/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics Unveils Promising Study Results for RLF-OD032

Clinical Study Patent Filing RLF-OD032 Phenylketonuria Drug Absorption
BRIEF

published on 10/25/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics dévoile les résultats prometteurs d'une étude sur RLF-OD032

Étude Clinique RLF-OD032 Dépôt De Brevet Phénylcétonurie Absorption Des Médicaments
PRESS RELEASE

published on 10/25/2024 at 07:00, 1 year 9 months ago

Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents
Relief Therapeutics reports positive study results for RLF-OD032, showing superior absorption in fasted state compared to KUVAN®, enabling flexible dosing. New patents filed for innovative PKU treatment

Study Results Relief Therapeutics RLF-OD032 Phenylketonuria Provisional Patents
BRIEF

published on 10/21/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics Secures European Patent for RLF-TD011

Orphan Drug Designation Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
BRIEF

published on 10/21/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics obtient un brevet européen pour RLF-TD011

Désignation De Médicament Orphelin THÉRAPEUTIQUE DE SECOURS RLF-TD011 Brevet Européen Epidermolyse Bulleuse
PRESS RELEASE

published on 10/21/2024 at 07:00, 1 year 9 months ago

Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment
Relief Therapeutics receives Notice of Allowance for European Patent covering RLF-TD011 for Epidermolysis Bullosa wound treatment. The patent will protect RLF-TD011 until 2040 in key European countries, with applications under review in other major markets

Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa Wound Treatment
BRIEF

published on 10/08/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics Reveals Promising Results in Clinical Trial for Epidermolysis Bullosa

Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Microbiome Diversity
BRIEF

published on 10/08/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics révèle des résultats prometteurs dans un essai clinique sur l'épidermolyse bulleuse

Essai Clinique THÉRAPEUTIQUE DE SECOURS RLF-TD011 Epidermolyse Bulleuse Diversité Du Microbiome
PRESS RELEASE

published on 10/08/2024 at 07:00, 1 year 9 months ago

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics reports promising preliminary results of RLF-TD011 clinical trial for epidermolysis bullosa, showing reduced Staphylococcus aureus and improved microbiome diversity

Microbiome Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa

Accesswire

Published on 07/31/2026 at 14:30, 5 hours 7 minutes ago

Unusual Machines Participating in Upcoming August Investor Conferences
Published on 07/31/2026 at 13:30, 6 hours 7 minutes ago

ZTEST Electronics Inc. Announces the Appointment of Dave Barnett as President and Chief Executive Officer Effective August 24, 2026
Published on 07/31/2026 at 13:30, 6 hours 7 minutes ago

Algo Grande Provides Phase II Drill Update; Commences Hole 3 with Second Drill Rig at Cerro Grande
Published on 07/31/2026 at 13:05, 6 hours 32 minutes ago

Faraday Copper Files Management Information Circular for Special Meeting of Shareholders in Connection with its Acquisition of BHP's San Manuel Property
Published on 07/31/2026 at 13:00, 6 hours 37 minutes ago

Nepra Foods Inc. Announces Filing of Annual Financial Statements and Management's Discussion and Analysis for the Year Ended March 31, 2026

View all ACCESSWIRE

EQS Group

Published on 07/31/2026 at 19:05, 32 minutes ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 42 minutes ago

Holding(s) in Company
Published on 07/31/2026 at 18:53, 43 minutes ago

Deutsche EuroShop SE: Conversion into a European Company Successfully Completed
Published on 07/31/2026 at 18:40, 57 minutes ago

EQS-Adhoc: VIB Vermögen AG: Lock-Up Agreements with noteholders and promissory noteholders of BRANICKS Group AG have become fully effective
Published on 07/31/2026 at 18:40, 57 minutes ago

NNS acquires shares in OCI

Les Echos

Published on 07/31/2026 at 19:27, 10 minutes ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:27, 10 minutes ago

Engagements de conservation d’actions (Pacte Dutreil)
Published on 07/31/2026 at 19:14, 23 minutes ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 23 minutes ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 19:13, 23 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 29 juillet 2026 au 31 juillet 2026

View all LES ECHOS COMFI WIRE